The Archive · 5 posts
Decode healthcare data with IXICO (IXI)! 🚀 Revolutionising brain health on the LSE with cutting-edge artificial intelligence. 🌟
IXICO reports strong H1 2026: revenue up 23%, gross margin 53.2%, order book £18.1m. Cash burn addressed with £10m fundraise. TechBio strategy unveiled.
May 19, 2026
Showing 4 of 5 posts
IXICO reports 23% revenue growth, a 38% larger order book, and a £10m capital raise to fuel its Tech Bio strategy. Strong H1 momentum.
JoshuaApril 21, 2026
IXICO's FY25: Revenue climbs 13%, order book jumps 27% post-year-end on a bullish Phase 3 Huntington's win.
JoshuaDecember 9, 2025
JoshuaOctober 16, 2025
IXICO's H1 2025 update: 26% revenue growth to £3.2m, Alzheimer's & Parkinson's focus with £13.1m order book. Progress in neurodegenerative disease research.
JoshuaApril 16, 2025
October 16, 2025